From: The clinical relevance of autoantibodies in scleroderma
SSc versus: | Sensitivity (%) | Specificity (%) |
---|---|---|
Normal controls | 33* †| 99.9* †|
Other connective tissue diseases | 31* | 95†-97* |
Primary Raynaud's phenomenon | 24* | 90* |
Non-SSc relatives | 19* | >99†* |